IEFM
IONS icon

IQ EQ Fund Management’s Ionis Pharmaceuticals IONS Stock Holding History

IQ EQ Fund Management’s Portfolio IONS Stock Details IONS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.25M Buy
15,819
+1,430
+10% +$108K 0.08% 207
2026
Q1 		$1.08M Sell
14,389
-779
-5% -$61.5K 0.08% 206
2025
Q4 		$1.2M Sell
15,168
-116
-0.8% -$8.73K 0.08% 194
2025
Q3 		$1,000K Buy
15,284
+2,021
+15% +$98.7K 0.07% 206
2025
Q2 		$524K Buy
13,263
+5,204
+65% +$170K 0.05% 253
2025
Q1 		$243K Buy
+8,059
New +$264K 0.03% 272

Other funds holding IONS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

IQ EQ Fund Management's IONS Position: Q2 2026 in Review

IQ EQ Fund Management increased its Ionis Pharmaceuticals (IONS) stake by 9.9% in Q2 2026, buying an estimated $108K and bringing the position to 15,819 shares worth $1.25M. The position accounts for 0.08% of the portfolio, ranked #207.

IQ EQ Fund Management first reported a position in IONS in Q1 2025 and has held it in 6 quarters since. 514 funds tracked by Wall St. Rank hold IONS as of Q2 2026.

  • IQ EQ Fund Management held 15,819 shares of Ionis Pharmaceuticals worth $1.25M as of Q2 2026.
  • IQ EQ Fund Management bought 1,430 Ionis Pharmaceuticals shares in Q2 2026, an estimated $108K.
  • Ionis Pharmaceuticals made up 0.08% of IQ EQ Fund Management's portfolio in Q2 2026, its #207 holding.
  • IQ EQ Fund Management first reported a position in Ionis Pharmaceuticals in Q1 2025 and has held it in 6 quarters since.
  • 514 funds tracked by Wall St. Rank held Ionis Pharmaceuticals as of Q2 2026.

Based on IQ EQ Fund Management's 13F filing for Q2 2026, filed 31 Jul 2026.